Hostname: page-component-76fb5796d-22dnz Total loading time: 0 Render date: 2024-04-28T05:28:20.126Z Has data issue: false hasContentIssue false

The Investigation of the Effects of Psychiatric Treatment

Published online by Cambridge University Press:  08 February 2018

B. Fox*
Affiliation:
Psychology Department, Institute of Psychiatry, London

Extract

The first aim of the study reported in this paper was to check Foulds's finding that claims for the success of a treatment were related to the degree of experimental control which authors exercised in their investigations (77). Foulds, from a selection of papers appearing between 1951 and 1956, showed that five studies (6·9 per cent, of the total) were controlled and claimed success, 15 (20·8 per cent, of the total) were controlled and claimed failure, 43 (59·7 per cent, of the total) were uncontrolled and claimed success and 9 (12·5 per cent. of the total) were uncontrolled and reported failure.

Type
Original Articles
Copyright
Copyright © Royal College of Psychiatrists, 1961 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

References

1 Abrams, J., “Therapeutic Value of Chlorpromazine in Effecting certain Psychological Changes”, Dissert. Abstr., 1957, 17, 589.Google Scholar
2 Algeo, N. B., and Pullen, M. S., “Personality Changes following Transorbital Lobotomy”, J. Clin. Psychol, 1957, 13, 308.Google Scholar
3 Baker, A., and Thorpe, J. G., “The Placebo Response”, Arch. Neur. Psychiat., 1957, 78, 57.Google Scholar
4 Bauer, R. W., and Johnson, D. G., “The Question of Deterioration in Alcoholism”, J. Consult. Psychol., 1957, 21, 296.CrossRefGoogle Scholar
5 Beck, S. J., and Molish, H. B., “Course in the Individual Patient as Traced in the Six Schizophrenias”, J. Nerv. Ment. Dis., 1957, 125, 403.Google Scholar
6 Beilin, H., “Prediction of Adjustment over a Four Year Interval”, J. Clin. Psychol, 1957, 13, 270.Google Scholar
7 Boling, L., Ryan, W., and Greenblatt, M., “Insulin Treatment of Psychotics”, Amer. J. Psychiat., 1957, 113, 1009.Google Scholar
8 Brill, N. Q., Crumpton, E., Eiduson, S., Grayson, H. M., Hellman, L. I., Richards, R. A., Strassman, H. D., and Unger, A., “Investigation of the Therapeutic Components of E.C.T.”, ibid., 1957, 113, 997.Google Scholar
9 Brown, C. C., “Changes in Avoidance Conditioning following Psychotherapeutic Treatment”, J. Nerv. Ment. Dis., 1957, 125, 487.CrossRefGoogle Scholar
10 Browne-Mayers, A. N., Henley, T. F., and Ostwald, P. F., “Grand Mal Convulsions following more than 150 E.C.T.s”, Psychiat. Quart., 1957, 31, 109.Google Scholar
11 Cartwright, D. S., and Roth, I., “Success and Satisfaction in Psychotherapy”, J. Clin. Psychol., 1957, 13, 20.Google Scholar
12 Cohen, S. I., Silverman, A. J., Zuidema, G., and Lazal, C., “Psychotherapeutic Alteration of Physiological Stress Responses”, J. Nerv. Ment. Dis., 1957, 125, 112.Google Scholar
13 Craft, M., “Tranquillizers in Mental Deficiency”, J. Ment. Sci., 1957, 103, 855.CrossRefGoogle Scholar
14 Cronholm, B., and Molander, L., “Memory Disturbance after E.C.T.”, Acta. Psychiat. Neurol. Scand., 1957, 32, 280.Google Scholar
15 Cutler, R., Monroe, J. J., and Anderson, T. E., “Effects of Tranquillizers on Pathological Activity of Psychotics. I—Chlorpromazine”, Arch. Neurol. Psychiat., 1957, 77, 616.Google Scholar
16 Iidem , “Effects of Tranquilizers on Pathological Activity in Psychotics. II—Reserpine”, ibid., 1957, 78, 61.Google Scholar
17 Dana, R. H., “M.M.P.I. Performance and E.C.T.”, J. Clin. Psychol, 1957, 13, 250.Google Scholar
18 De Wet, J. S. Du T., “Evaluation of a Common Method of Convulsive Therapy in Bantu Schizophrenics”, J. Ment. Sci., 1957, 103, 739.CrossRefGoogle Scholar
19 Dittes, J., “Galvanic Skin Response as a Measure of Patients' Reactions to Therapists' Permissiveness”, J. Abn. Soc. Psychol., 1957, 55, 295.CrossRefGoogle Scholar
20 Ellsworth, R. B., and Clark, L. D., “Prediction of Response of Chronic Schizophrenics to Drugs”, J. Clin. Psychol., 1957, 13, 59.Google Scholar
21 Feldman, P. E., “Clinical Evaluation of Pacatal”, Amer. J. Psychiat., 1957, 114, 143.Google Scholar
22 Idem , “A Comparative Study of Various Ataractic Drugs”, ibid., 1956–57, 113, 589.Google Scholar
23 Idem , “Two Year Fate Study of Thorazine Treated Patients”, ibid., 1957, 114, 237.Google Scholar
24 Foundeur, M., Fixsen, C., Triebel, W. A., and White, M. A., “Post-partum Mental Illness”, Arch. Neurol. Psychiat., 1957, 77, 503.CrossRefGoogle Scholar
25 Frank, J. D., Gliedman, L. H., Imber, S. D., Nash, E. H., and Stone, A. R., “Why Patients Leave Psychotherapy”, ibid., 1957, 77, 283.Google Scholar
26 Gordon, M. H., Lindley, S. B., and May, R. B., “A Criterion Measure of Within-Hospital Change in Psychiatric Illness”, J. Clin. Psychol., 1957, 13, 145.3.0.CO;2-H>CrossRefGoogle Scholar
27 Gore, C. P., Egan, G. P., and Walton, D., “The Place of Reserpine in the Treatment of Chronic Psychotics”, Amer. J. Psychiat., 1957, 114, 333.Google Scholar
28 Hauck, P., Phillips, H., and Armstrong, R., “The Effects of Reserpine on Psychotics of Varying Degrees of Illness”, J. Clin. Psychol., 1957, 13, 188.Google Scholar
29 Heller, G. C., Walton, D., and Black, D. A., “Meprobamate in the Treatment of Tension States”, J. Ment. Sci., 1957, 103, 581.Google Scholar
30 Heller, E., “Language Before and After Lobotomy”, Dissert. Abst., 1957, 17, 2086.Google Scholar
31 Hill, D., Pond, D. A., and Falconer, M. A., “Personality Changes following Temporal Lobectomy for Epilepsy”, J. Ment. Sci., 1957, 103, 18.Google Scholar
32 Hill, H. E., Belleville, R. E., and Wikler, A., “Motivational Determinants in Modification of Behaviour by Morphine and Pentobarbital”, Arch. Neur. Psychiat., 1957, 77, 28.Google Scholar
33 Imber, S. D., Frank, J. D., Nash, E. H., Stone, A. R., and Gliedman, L. H., “Improvement and Amount of Therapeutic Contact: An Alternative to the Use of No-Treatment Controls in Psychotherapy”, J. Consult. Psychol., 1957, 21, 309.Google Scholar
34 Kalis, B. L., and Bennett, L. F., “The Assessment of Communication: the Relation of Clinical Improvement to Measured Changes in Communicative Behaviour”, ibid., 1957, 21, 10.Google Scholar
35 Kelman, H. C., and Parloff, M. B., “Inter-relation Among Three Criteria of Improvement in Group Therapy”, J. Abn. Soc. Psychol, 1957, 54, 281.CrossRefGoogle Scholar
36 King, P., “A Statistical Comparison of Two Methods of E.C.T.”, Amer. J. Psychiat., 1957, 114, 555.Google Scholar
37 Krawiecki, J. A., Couper, L., and Walton, D., “The Efficacy of Parentrovite in the Treatment of Senile Psychotics”, J. Ment. Sci., 1957, 103, 601.Google Scholar
38 Lehman, E., Haber, J., and Lesser, S. R., “The Use of Reserpine in Autistic Children”, J. Nerv. Ment. Dis., 1957, 125, 351.Google Scholar
39 Lesse, S., Malitz, S., and Hoch, P., “Chlorpromazine Therapy in Private Practice”, ibid., 1957, 125, 25.Google Scholar
40 Idem , “An Evaluation of Promazine Hydrochloride in Psychiatric Practice”, Amer. J. Psychiat., 1957, 113, 984.Google Scholar
41 Levine, D., “Differential Effects of Factors in an Activity Program”, ibid., 1957, 114, 532.Google Scholar
42 Mason-Browne, N. L., “Perphenazine—A Drug Modifying Consciousness”, ibid., 1957, 114, 173.Google Scholar
43 McAdam, W., and Robinson, R. A., “Prognosis in Senile Deterioration”, J. Ment. Sci., 1957, 103, 821.Google Scholar
44 Merlis, S., “The Effects of Mescaline Sulfate in Chronic Schizophrenia”, J. Nerv. Ment. Dis., 1957, 125, 432.Google Scholar
45 Merry, J., Pargiter, R. A., and Munro, H., “Chlorpromazine and Chronic Neurotic Tension”, Amer. J. Psychiat., 1957, 113, 988.Google Scholar
46 Mundy, L., “Therapy with Physically and Mentally Handicapped Children”, J. Clin. Psychol., 1957, 13, 3.Google Scholar
47 Niswander, G. D., Haslerud, G. M., Brody, N., and Casey, T. M., “Reserpine and Ritalin—Effects on Socialization and Activity”, J. Nerv. Ment. Dis., 1957, 125, 51.CrossRefGoogle Scholar
48 Pate, W. H., “Chlorpromazine Therapy following Transorbital Lobotomy”, ibid., 1957, 125, 44.Google Scholar
49 Peak, E. C., Canestrari, R. E., and Roebuck, B. E., “Effects of Frenquel on Chronically Disturbed Patients”, Amer. J. Psychiat., 1957, 113, 653.CrossRefGoogle Scholar
50 Pennington, V., “The Use of Miltown with Psychotic Patients”, ibid., 1957, 114, 457.Google Scholar
51 Porteus, S. D., “Maze Test Reactions after Chlorpromazine”, J. Consult. Psychol., 1957, 21, 15.Google Scholar
52 Idem , “Specific Behavioural Changes following Chlorpromazine”, ibid., 1957, 21, 257.Google Scholar
53 Idem and Barclay, J. E., “A further note on Chlorpromazine”, ibid., 1957, 21, 297.Google Scholar
54 Rashkis, H., and Smarr, G. R., “Psychopharmacotherapeutic Research”, Arch. Neurol. Psychiat., 1957, 77, 202.Google Scholar
55 Iidem , “Drug and Milieu Effects on Chronic Schizophrenics”, ibid., 1957, 78, 89.Google Scholar
56 Robertson, M. H., “A Comparison of Client and Therapist Ratings on Two Psychotherapeutic Variables”, J. Consult. Psychol., 1957, 21, 110.Google Scholar
57 Idem , “Change and Receptiveness to Psychotherapy”, ibid., 1957, 21, 498.Google Scholar
58 Rosner, B. S., Fierman, L. B., and Kramer, J. F., “A Clinical Evaluation of Meratran and Frenquel on Chronic Psychotics”, Amer. J. Psychiat., 1957, 113, 993.CrossRefGoogle Scholar
59 Ryan, T., “Effects of Attention and Various Adjunctive Therapy Programs on Chronic Schizophrenics”, Diss. Abst., 1957, 17, 810.Google Scholar
60 Salisbury, B. J., and Hare, E. H., “Ritalin and Chlorpromazine in Chronic Schizophrenia”, J. Ment. Sci., 1957, 103, 830.Google Scholar
61 Scherer, I. W., Klett, C. J., and Winne, J. F., “Psychological Changes over a Five Year Period following Bilateral Prefrontal Lobotomy”, J. Consult. Psychol., 1957, 21, 291.Google Scholar
62 Schmidt, K. E., “Combined Treatment with Chlorpromazine and Reserpine”, J. Ment. Sci., 1957, 103, 200.CrossRefGoogle Scholar
63 Segal, L. J., and Tansley, A. E., “Clinical Trial of Hydroxyzine (Atarax) on a Group of Maladjusted E.S.N. Children”, ibid, 1957, 103, 677.Google Scholar
64 Semans, C. B., “The Use of the Semantic Differential with Lobotomized Psychotics”, J. Consult. Psychol., 1957, 21, 264.Google Scholar
65 Semon, R. G., and Goldstein, N., “The Effectiveness of Group Psychotherapy with Chronic Schizophrenics and an Evaluation of Different Therapeutic Methods”, ibid, 1957, 21, 317.Google Scholar
66 Sibilio, J. P., Andrew, G., Daw, D., Moore, K. B., and Stehman, V. A., “Treatment of Chronic Schizophrenics with Promazine Hydrochloride”, Arch. Neurol. Psychiat., 1957, 78, 419.Google Scholar
67 Standal, S. W., and Vander Veem, F., “Length of Therapy in Relation to Counselor Estimates of Personal Integration”, J. Consult. Psychol., 1957, 21, 1.CrossRefGoogle Scholar
68 Stenbäck, A., Viitamäki, R. O., and Kukkonen, S., “Personality Changes in E.C.T.”, Acta Psychiat. Neurol. Scand., 1957, 32, 345.Google Scholar
69 Iidem , “Psychological Studies on a Patient who Received 441 E.C.T.s”, ibid., 1957, 32, 473.Google Scholar
70 Thorne, F., “An Evaluation of Eclectically Orientated Therapy”, J. Consult. Psychol., 1957, 21, 459.CrossRefGoogle Scholar
71 Tucker, K., and Wilensky, H., “Clinical Evaluation of Meprobamate in Chronic Schizophrenics”, Amer. J. Psychiat., 1957, 113, 698.CrossRefGoogle Scholar
72 Tucker, H., Lewis, R. B., Martin, G. L., and Over, C. H. R., “Effectiveness of Closed-Circuit Television as a Medium for Therapy of the Mentally Ill”, Arch. Neurol. Psychiat., 1957, 77, 57.Google Scholar
73 Whitehead, W., “Effects of Chlorpromazine on Learning Tasks and Verbalized Social Adaptation”, Dissert. Abst., 1957, 13, 9.Google Scholar
74 Wilcox, G. T., and Guthrie, G. M., “Changes in Adjustment of Institutionalized Female Defectives following Group Psychotherapy”, J. Clin. Psychol., 1957, 13, 9.Google Scholar
75 Winckelmann, N. W., “An Appraisal of Chlorpromazine”, Amer. J. Psychiat., 1957, 113, 961.Google Scholar
76 Yormak, B., “Behavioural Changes following Semantic Training”, Dissert. Abst., 1957, 17, 402.Google Scholar

Other References

77 Foulds, G., “Clinical Research in Psychiatry”, J. Ment. Sci., 1958, 104, 259.Google Scholar
78 Shapiro, M. B., Kessell, R., and Maxwell, A. E., “Speed and Quality of Psychomotor Performance in Psychiatric Patients”, J. Clin. Psychol., 1960, 16, 266.3.0.CO;2-6>CrossRefGoogle Scholar
79 Staudt, V., and Zubin, J., “Evaluation of Somatic Therapies in Psychiatry”, Psychol. Bull., 1957, 54, 171.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.